Karim Fizazi
Université Paris-Saclay(FR)Huntsman Cancer Institute(US)University Medical Center Freiburg(DE)Institut Gustave Roussy(FR)Laboratoire d'études sur les monothéismes(FR)Centre Oscar Lambret(FR)
Publications by Year
Research Areas
Prostate Cancer Treatment and Research, Radiopharmaceutical Chemistry and Applications, Cancer, Lipids, and Metabolism, Cancer Genomics and Diagnostics, Prostate Cancer Diagnosis and Treatment
Most-Cited Works
- → Increased Survival with Enzalutamide in Prostate Cancer after Chemotherapy(2012)4,537 cited
- → Abiraterone and Increased Survival in Metastatic Prostate Cancer(2011)4,364 cited
- → Enzalutamide in Metastatic Prostate Cancer before Chemotherapy(2014)3,004 cited
- → Abiraterone in Metastatic Prostate Cancer without Previous Chemotherapy(2012)2,765 cited
- → Lutetium-177–PSMA-617 for Metastatic Castration-Resistant Prostate Cancer(2021)2,383 cited
- → Olaparib for Metastatic Castration-Resistant Prostate Cancer(2020)2,172 cited
- → Abiraterone plus Prednisone in Metastatic, Castration-Sensitive Prostate Cancer